✦ LIBER ✦

Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors

✍ Scribed by Plummer, Ruth; Stephens, Peter; Aissat-Daudigny, Louiza; Cambois, Anne; Moachon, Gilbert; Brown, Peter D.; Campone, Mario

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of tezacit

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

Phase I dose-escalating study of TAS-106

✍ Naing, Aung; Fu, Siqing; Zinner, Ralph G.; Wheler, Jennifer J.; Hong, David S.; 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 147 KB

Phase I dose-escalation study of AZD7762

✍ Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 560 KB

Phase I dose-escalation study of the HSP

✍ Toshihiko Doi,Yusuke Onozawa,Nozomu Fuse… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 733 KB

A phase I, dose-escalation study of the

✍ Hollebecque, A.; Deutsch, E.; Massard, C.; Gomez-Roca, C.; Bahleda, R.; Ribrag, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 445 KB

587 Phase 1 Dose-escalation Study of PF-

✍ Wagner, A.; Messersmith, W.; Shaik, N.; Zheng, X.; McLachlan, K.; Cesari, R.; Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB